Evidence map›Paper›PMID 21670593›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Chromium induces chromosomal instability, which is partly due to deregulation of BubR1 and Emi1, two APC/C inhibitors.

Liyan Hu, Xin Liu, Yana Chervona, Feikun Yang, Moon-shong Tang, Zbigniew Darzynkiewicz, Wei Dai

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Liyan HuDepartment of Environmental Medicine, New York University Langone Medical Center, Tuxedo, NY, USA.
Xin Liu
Yana Chervona
Feikun Yang
Moon-shong Tang
Zbigniew Darzynkiewicz
Wei Dai
New York University · USNYU Langone Health · USCatalyst Foundation · US

Funding

RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
Water/sediment &model &criteria for arsenic &chromeP42ES010344 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 2000 to 2010
$15.0M
PROBES FOR FLOW CYTOMETRYR01CA028704 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI DARZYNKIEWICZ, ZBIGNIEW · 1985 to 2014
$6.0M
Molecular mechanisms underlying chromosomal instability and aneuploidyR01CA090658 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAI, WEI · 2001 to 2012
$2.9M
Mechanisms of arsenic-induced chromosomal instability and carcinogenesisR01ES020591 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DAI, WEI · 2012 to 2016
$2.0M
NCI NIH HHS CA090658NCI NIH HHS R01 CA028704NCI NIH HHS R01 CA090658NIEHS NIH HHS ES000260NIEHS NIH HHS ES010344NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P42 ES010344NIEHS NIH HHS R01 ES020591
6 · The paper itself

Abstract

Disruption of cell cycle checkpoints and interference with the normal cell cycle progression frequently result in cell death or malignant transformation. Hexavalent chromium [Cr(VI)] is a well-known carcinogen that has been implicated in the occurrence of many types of human malignancies, including lung cancer. However, the exact mechanism by which Cr(VI) causes malignant transformation in the lung remains unknown. We have demonstrated that chronic exposure to a non-cytotoxic concentration of Cr(VI) induced a variety of chromosomal abnormalities, including premature sister chromatid separation, chromosomal breakage and the presence of lagging/misaligned chromosomes. After treatment with nocodazole, both HeLa and normal lung bronchial epithelial cells were arrested at mitosis. However, Cr(VI) significantly compromised M-phase arrest induced by nocodazole. Cr(VI) suppressed BubR1 activation and reduced expression of Emi1, leading to an unscheduled activation of APC/C. Consistent with this observation, Cr(VI) treatment caused enhanced polyubiquitination of geminin during mitotic release, while it deregulated the activity of Cdt1, a DNA replication licensing factor. Combined, these results suggest that Cr(VI)-induced chromosomal instability is partly due to a perturbation of APC/C activities, leading to chromosomal instability.

Indexed as

Chromosomal InstabilityAdenomatous Polyposis Coli ProteinAntineoplastic AgentsCell Cycle ProteinsCell DivisionChromiumF-Box ProteinsGemininHeLa CellsHumansMitosisNocodazoleProtein Serine-Threonine KinasesUbiquitinationAdenomatous Polyposis Coli ProteinAntineoplastic AgentsAPC protein, humanBUB1 protein, humanBub1 spindle checkpoint proteinCDT1 protein, humanCell Cycle ProteinsChromiumchromium hexavalent ionF-Box ProteinsFBXO5 protein, humanGemininGMNN protein, humanNocodazoleProtein Serine-Threonine Kinases

Identifiers

PMID21670593
PMCPMC3230526
OpenAlexW2089668233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.